Skip to main content

Want a detailed portfolio tracker?

Alterity Therapeutics (ATHE) P/E (2019 - 2026)

Alterity Therapeutics (ATHE) P/E from Jul 1, 2019 to Jul 21, 2026. The TTM Alterity Therapeutics (ATHE) P/E is -3.43. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alterity Therapeutics (ATHE)

YearP/EChange
2026-3.43+57.47%
2025-2.18+37.65%
2024-1.58+107.88%
2023-0.76+46.63%
2022-0.52-34.08%
2021-0.79-20.99%
2020-1.00-11.22%
2019-1.12N/A

Comparison Alterity Therapeutics (ATHE) P/E with competitors

Alterity Therapeutics (ATHE) P/E is -3.43.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.18%
FGENFibroGen Inc0.24-107.00%
CHRSCoherus Biosciences Inc0.85-124.75%
FBIOFortress Biotech Inc0.95-127.68%
ORMPOramed Pharmaceuticals Inc1.50-143.84%
AGENAgenus Inc3.01-187.78%
INVAInnoviva Inc3.15-192.00%
VXRTVaxart Inc3.55-203.54%
CRMDCorMedix Inc3.63-205.83%
CVACCureVac N.V.4.45-229.67%
GLPGGalapagos NV4.86-241.72%
SRPTSarepta Therapeutics Inc4.88-242.40%
ABEOAbeona Therapeutics Inc5.39-257.14%
ABUSArbutus Biopharma Corp5.60-263.21%
ZVRAZevra Therapeutics Inc5.89-271.72%
SPROSpero Therapeutics Inc6.23-281.67%
CGENCompugen Ltd6.31-284.16%
RIGLRigel Pharmaceuticals6.87-300.44%
SLXNSilexion Therapeutics Corp7.30-312.81%
OMEROmeros Corporation9.26-370.06%
AUPHAurinia Pharmaceuticals Inc9.58-379.57%
PLXProtalix BioTherapeutics Inc10.89-417.66%
ACADAcadia Pharmaceuticals Inc11.73-442.09%
TBPHTheravance Biopharma Inc12.26-457.66%
ADMAAdma Biologics Inc12.42-462.21%
HRMYHarmony Biosciences Holdings Inc13.82-503.10%
SABSSAB Biotherapeutics Inc14.14-512.32%
NAGENiagen Bioscience Inc14.82-532.21%
INCYIncyte Corp15.82-561.51%
REGNRegeneron Pharmaceuticals Inc15.86-562.50%
PBYIPuma Biotechnology Inc17.32-605.06%
CPRXCatalyst Pharmaceuticals Inc17.44-608.66%
EXELExelixis Inc17.54-611.54%
TGTXTG Therapeutics Inc18.97-653.20%
MDXGMimedx Group Inc20.55-699.47%
XOMAXOMA Royalty Corp22.87-767.22%
ARGXArgen X SE24.30-808.74%
CTMXCytomX Therapeutics Inc24.82-823.99%
XOMAOXOMA Royalty Corp25.34-839.27%
HALOHalozyme Therapeutics Inc25.62-847.40%
XOMAPXOMA Royalty Corp25.67-848.76%
VRTXVertex Pharmaceuticals Inc27.99-916.56%
RPRXRoyalty Pharma plc - Class A28.69-936.77%
SLNOSoleno Therapeutics Inc29.02-946.33%
ASNDAscendis Pharma A/S30.09-977.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1205.84%
APLSApellis Pharmaceuticals Inc39.02-1238.19%
BMRNBiomarin Pharmaceutical Inc42.21-1331.26%
KRYSKrystal Biotech Inc45.34-1422.60%
ONCBeiGene Ltd69.54-2128.39%
PHARPharming Group N.V.75.03-2288.38%
TECHBio-Techne Corp101.96-3073.97%
VCELVericel Corp109.92-3306.24%
ALNYAlnylam Pharmaceuticals Inc117.96-3540.86%
GMABGenmab140.29-4192.07%
TLXTelix Pharmaceuticals Ltd162.15-4829.75%
CORTCorcept Therapeutics Inc212.86-6308.73%